BIODESIX INC (BDSX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $18.99M | -27.7% |
| 2024 | $26.25M | -0.1% |
| 2023 | $26.28M | -39.0% |
| 2022 | $43.09M | +31.7% |
| 2021 | $32.71M | -47.3% |
| 2020 | $62.13M | +1075.3% |
| 2019 | $5.29M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $18.99M | -27.7% |
| 2024 | $26.25M | -0.1% |
| 2023 | $26.28M | -39.0% |
| 2022 | $43.09M | +31.7% |
| 2021 | $32.71M | -47.3% |
| 2020 | $62.13M | +1075.3% |
| 2019 | $5.29M | — |